BMI Stock Analysis: Buy, Sell, or Hold?
BMI - Badger Meter, Inc.
$114.23
-3.31 (-2.82%)
▼
5d:
-3.62%
30d:
-24.99%
90d:
-26.25%
BUY
HIGH Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: Apr 17, 2026
0d
Get Alerted When BMI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BMI trading at deep discount. Market pricing in -6.9% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: BMI trading at deep discount. Market pricing in -6.9% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$170.86
Based on 6.7% avg growth
INTRINSIC VALUE TODAY
$106.09
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BMI is currently trading at $114.23, which is considered slightly low relative to its 30-day fair value range of $112.73 to $146.20. From a valuation perspective, the stock is trading at a discount (Forward PE: 23.0) compared to its historical average (28.6). Remarkably, the market is currently pricing in an annual earnings decline of 6.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BMI is in a strong downtrend. The price is currently testing key support at $114.04. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $147.00 (+28.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BMI is in a strong downtrend. The price is currently testing key support at $114.04. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $147.00 (+28.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$112.73 -
$146.20
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 28.7% below Wall St target ($147.00)
Trading Range Analysis
30-Day Trading Range
$112.73 -
$146.20
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$114.04
Resistance Level
$125.50
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.04
Wall Street Target
$147.00
(+28.7%)
Revenue Growth (YoY)
-9.0%
Earnings Growth (YoY)
-28.5%
Profit Margin
14.6%
Valuation Discount vs History
-6.9% cheaper
PE vs Historical
23.0 vs 28.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.9%
(market-implied from PE analysis)
1-Year Target
$106.35
(-7%)
2-Year Target
$99.01
(-13%)
3-Year Target
$92.18
(-19%)
3-Yr Target (if PE normalizes)
(PE: 23→29)
$114.40
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.0, Growth: 9.3%)
$149.00
(+30%)
Base:
(SPY PE: 22.1, Growth: 9.3%)
$142.70
(+25%)
Bear:
(PE: 18.8, Growth: 9.3%)
$121.30
(+6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Trailing PE: 26.59 | Current EPS (TTM): $4.42
Bull Case
$145.00
(+27%)
Analyst growth 12.1%, PE expands to 29.3
Base Case
$131.82
(+15%)
Market implied 12.1%, PE stable at 26.6
Bear Case
$79.93
(-30%)
Severe decline -20.0%, PE contracts to 22.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 23.0 to 28.6
Stabilization Target:
$141.77
(+24.1%)
PE Expansion Potential:
+24.1%
Share & Embed Analysis
Last updated: May 16, 2026 6:57 AM ET
Data refreshes hourly during market hours. Next update: 7:57 AM
Data refreshes hourly during market hours. Next update: 7:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BMI showing a specific setup today?
Insider Activity (6 Months)
7
Buys
4
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Robert Wrocklage
BUY
1000 shares
2026-04-23
Christina M Tarantino
BUY
870 shares
2026-04-21
Edward F Callahan
BUY
858 shares
2026-04-21
Top Rated Scientific & Technical Instruments Stocks
Top-rated stocks in Scientific & Technical Instruments by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
COHR
Coherent Inc |
STRONG BUY
19 analysts |
$356 | 62 BUY |
|
FTV
Fortive Corp |
BUY
20 analysts |
$63 | 61 BUY |
|
TRMB
Trimble Inc |
STRONG BUY
12 analysts |
$87 | 60 HOLD |
|
CGNX
Cognex Corporation |
BUY
20 analysts |
$73 | 56 HOLD |
|
MKSI
MKS Instruments Inc |
STRONG BUY
12 analysts |
$357 | 55 HOLD |
Advanced BMI Option Strategies
Professional options setups generated by AI based on today's BMI price and gamma walls.